Orphan Technologies
Research - Lexington, Massachusetts, United States
Orphan Technologies Employees
Orphan Technologies Details
Orphan Technologies is committed to reduce the burden of patients suffering from homocystinuria. OT-58, our lead drug development candidate, has been optimized as an enzyme therapy for classical homocystinuria, a genetic disease characterized by debilitating cardiovascular, skeletal, neurologic, and ophthalmologic complications. OT-58 is designed to reduce homocysteine levels via a targeted mechanism of action and may have therapeutic applications in other diseases.
Website:
http://www.orphantechnologies.com
Employees:
6
HQ:
+1 781-966-3830
Location:
Lexington, Massachusetts, United States
Revenue:
3.2M
Orphan Technologies Technologies
Email Providers
Gmail
SSL Certificates
Media Temple SSL
Other
Google Apps